377 related articles for article (PubMed ID: 22022944)
1. Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer.
Sempere LF
Expert Rev Mol Diagn; 2011 Nov; 11(8):813-27. PubMed ID: 22022944
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs: key players in carcinogenesis and novel therapeutic targets.
Mirnezami AH; Pickard K; Zhang L; Primrose JN; Packham G
Eur J Surg Oncol; 2009 Apr; 35(4):339-47. PubMed ID: 18644693
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs as Promising Tumor Biomarkers.
Chen M; Calin GA; Meng QH
Adv Clin Chem; 2014; 67():189-214. PubMed ID: 25735862
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
To KK; Tong CW; Wu M; Cho WC
World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
[TBL] [Abstract][Full Text] [Related]
5. miRNA in a multiomic context for diagnosis, treatment monitoring and personalized management of metastatic breast cancer.
Zubor P; Kubatka P; Dankova Z; Gondova A; Kajo K; Hatok J; Samec M; Jagelkova M; Krivus S; Holubekova V; Bujnak J; Laucekova Z; Zelinova K; Stastny I; Nachajova M; Danko J; Golubnitschaja O
Future Oncol; 2018 Aug; 14(18):1847-1867. PubMed ID: 30019928
[TBL] [Abstract][Full Text] [Related]
6. Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network.
Zhu Y; Peng Q; Lin Y; Zou L; Shen P; Chen F; Min M; Shen L; Chen J; Shen B
Oncotarget; 2017 Jan; 8(2):2233-2248. PubMed ID: 27903980
[TBL] [Abstract][Full Text] [Related]
7. The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment.
Davey MG; Davies M; Lowery AJ; Miller N; Kerin MJ
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361056
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in cancer: personalizing diagnosis and therapy.
Nana-Sinkam SP; Fabbri M; Croce CM
Ann N Y Acad Sci; 2010 Oct; 1210():25-33. PubMed ID: 20973796
[TBL] [Abstract][Full Text] [Related]
9. miRNA Expression Profiles in Luminal A Breast Cancer-Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment.
Kudela E; Samec M; Koklesova L; Liskova A; Kubatka P; Kozubik E; Rokos T; Pribulova T; Gabonova E; Smolar M; Biringer K
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33080858
[TBL] [Abstract][Full Text] [Related]
10. Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine?
Sempere LF
Expert Rev Mol Diagn; 2014 Sep; 14(7):853-69. PubMed ID: 25090088
[TBL] [Abstract][Full Text] [Related]
11. Cluster miRNAs and cancer: Diagnostic, prognostic and therapeutic opportunities.
Kabekkodu SP; Shukla V; Varghese VK; Adiga D; Vethil Jishnu P; Chakrabarty S; Satyamoorthy K
Wiley Interdiscip Rev RNA; 2020 Mar; 11(2):e1563. PubMed ID: 31436881
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs as biomarkers in colorectal cancer.
Schee K; Fodstad Ø; Flatmark K
Am J Pathol; 2010 Oct; 177(4):1592-9. PubMed ID: 20829435
[TBL] [Abstract][Full Text] [Related]
13. Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies.
Du X; Zhang J; Wang J; Lin X; Ding F
Curr Pharm Des; 2018 Feb; 23(39):5997-6010. PubMed ID: 28714414
[TBL] [Abstract][Full Text] [Related]
14. Updates and current challenges in microRNA research for personalized medicine in ovarian cancer.
Mandilaras V; Vernon M; Meryet-Figuière M; Karakasis K; Lambert B; Poulain L; Oza A; Denoyelle C; Lheureux S
Expert Opin Biol Ther; 2017 Aug; 17(8):927-943. PubMed ID: 28641048
[TBL] [Abstract][Full Text] [Related]
15. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
16. [Role of contemporary pathological diagnostics in the personalized treatment of cancer].
Tímár J
Magy Onkol; 2013 Mar; 57(1):26-32. PubMed ID: 23573519
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.
van Schooneveld E; Wildiers H; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
Breast Cancer Res; 2015 Feb; 17():21. PubMed ID: 25849621
[TBL] [Abstract][Full Text] [Related]
18. miRNAs as biomarkers for management of patients with colorectal cancer.
Manne U; Shanmugam C; Bovell L; Katkoori VR; Bumpers HL
Biomark Med; 2010 Oct; 4(5):761-70. PubMed ID: 20945991
[TBL] [Abstract][Full Text] [Related]
19. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
